Serogroup B Neisseria meningitidis is a frequent cause of invasive meningococcal disease, yet there are no effective vaccines suitable for routine immunisation. Limited efficacy has been shown with meningococcal outer membrane vacccines in children 4 years and older. Here we review the status of current research and consider new approaches to development of meningococcal serogroup B vaccines
Novel serogroup B meningococcal vaccines are currently in late stage development and may be used in ...
The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era wit...
The past century has seen the use of a number of vaccines for prevention and control of meningococca...
Serogroup B Neisseria meningitidis is a frequent cause of invasive meningococcal disease, yet there ...
Most invasive meningococcal disease in developed countries is caused by Neisseria meningitidis with ...
Invasive disease caused by Neisseria meningitidis is associated with high mortality and high disabil...
The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C mening...
Meningococcal disease remains a significant global public health issue and is unique among causes of...
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge ...
The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C mening...
Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. ...
Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. ...
Invasive infections caused by Neisseria meningitidis are a serious public health problem worldwide a...
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge ...
The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era wit...
Novel serogroup B meningococcal vaccines are currently in late stage development and may be used in ...
The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era wit...
The past century has seen the use of a number of vaccines for prevention and control of meningococca...
Serogroup B Neisseria meningitidis is a frequent cause of invasive meningococcal disease, yet there ...
Most invasive meningococcal disease in developed countries is caused by Neisseria meningitidis with ...
Invasive disease caused by Neisseria meningitidis is associated with high mortality and high disabil...
The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C mening...
Meningococcal disease remains a significant global public health issue and is unique among causes of...
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge ...
The successful introduction of a protein-polysaccharide conjugate vaccine against serogroup C mening...
Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. ...
Neisseria meningitidis is an important cause of invasive bacterial infection in children worldwide. ...
Invasive infections caused by Neisseria meningitidis are a serious public health problem worldwide a...
The widespread use of meningococcal polysaccharide conjugate vaccines has highlighted the challenge ...
The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era wit...
Novel serogroup B meningococcal vaccines are currently in late stage development and may be used in ...
The prevention of paediatric bacterial meningitis and septicaemia has recently entered a new era wit...
The past century has seen the use of a number of vaccines for prevention and control of meningococca...
DOI
Add to ORKG